These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3209911)
1. [Distribution of oncotrophoblast antigens defined by monoclonal antibodies]. Inoue R Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1837-43. PubMed ID: 3209911 [TBL] [Abstract][Full Text] [Related]
2. [The differentiation antigen of trophoblast expressed on trophoblastic neoplasms (choriocarcinoma and hydatidiform mole) detected by monoclonal antibodies]. Nakamura T; Yamashita K Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):477-84. PubMed ID: 3701139 [TBL] [Abstract][Full Text] [Related]
3. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535 [TBL] [Abstract][Full Text] [Related]
4. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human choriocarcinoma. Yamashita K; Nakamura T; Shimizu T; Ohno H Am J Reprod Immunol Microbiol; 1986 Aug; 11(4):130-4. PubMed ID: 3532836 [TBL] [Abstract][Full Text] [Related]
6. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody]. Suzuki H; Teshima K; Noda K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978 [TBL] [Abstract][Full Text] [Related]
7. Ca-125 levels in the conditioned media of the gynecological tumor cell lines. Ishiwata I; Ishiwata C Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943 [No Abstract] [Full Text] [Related]
8. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer]. Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320 [TBL] [Abstract][Full Text] [Related]
9. [Tissue polypeptide antigen in gynecological cancer]. Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803 [TBL] [Abstract][Full Text] [Related]
10. New monoclonal antibody, 1C5, reactive with human cervical adenocarcinoma of the uterus, with immunodiagnostic potential. Koizumi M; Uede T; Shijubo N; Kudo R; Hashimoto M; Kikuchi K Cancer Res; 1988 Nov; 48(22):6565-72. PubMed ID: 3052807 [TBL] [Abstract][Full Text] [Related]
11. Identification of a human cancer-associated antigen defined with monoclonal antibody. Bhattacharya M; Chatterjee SK; Barlow JJ Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708 [TBL] [Abstract][Full Text] [Related]
12. [Significance of CA 125 antigen levels in patients with ovarian cancer]. Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806 [TBL] [Abstract][Full Text] [Related]
13. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Friedman EL; Hayes DF; Kufe DW Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435 [TBL] [Abstract][Full Text] [Related]
14. [Development of the monoclonal antibody to cultured uterine endometrial adenocarcinoma cells (EI)]. Yudate T; Isaka K; Okabe K; Takayama M Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul; 47(7):635-42. PubMed ID: 7636334 [TBL] [Abstract][Full Text] [Related]
15. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies. Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies. Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560 [TBL] [Abstract][Full Text] [Related]
17. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus]. Gadducci A; Facchini V; Bartolini T; Fioretti P Ann Ostet Ginecol Med Perinat; 1988; 109(3):151-5. PubMed ID: 3207319 [No Abstract] [Full Text] [Related]
18. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors. Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386 [TBL] [Abstract][Full Text] [Related]
19. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Shitara K; Hanai N; Yoshida H Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444 [TBL] [Abstract][Full Text] [Related]
20. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies]. Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322 [No Abstract] [Full Text] [Related] [Next] [New Search]